Brussels, 07/09/2011 (Agence Europe) - The current revision of two European directives that are crucial to successful research into blood-related diseases must ensure the safety of patients and enhance their access to vitally-important treatment. This was a key message of a two-day conference, Haematology and the next European decade, hosted by the European Parliament and organised by the European Cancer Patient Coalition (ECPC) and the European Haematology Association. It was attended by...